Lou Gehrigs Disease - Global Strategic Business Report
- Language: English
- 258 Pages
- Published: April 2010
- Region: World
Landmark discoveries in the neurosciences are revolutionizing our understanding of the human brain and its chemical structure. This report from Frost & Sullivan covers new drugs designed to treat such diverse brain disorders as multiple sclerosis, ALS, Alzheimer s dementia, and stroke, as well as treatments for more mature markets. Competitive strategies, such as rereleasing new formulations of existing products, are discussed at length. And profiles for companies like Glaxo-Wellcome, Warner-Lambert, and Parke-Davis are included.
- Executive Summary
- The Richest Pipeline in the Industry
- Summary of Major Findings
- Conclusions
- Industry Challenges and Research Methodology
- Challenges Facing the Pharmaceutical Industry
- Time Frame Analysis of Industry Challenges
| Format | Properties | |
|---|---|---|
| Site License | The report will be emailed to you. The report is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Site License | A copy of the report will be emailed to you and a printed copy will be shipped to you. The Electronic copy is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |
| Enterprisewide | A copy of the report will be emailed to you and a printed copy will be shipped to you. The Electronic copy is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |